Selected research
Industry Research
Sodium Valproate Industry Research Report 2026
Market perspective
The global Sodium Valproate market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Sodium Valproate is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Sodium Valproate is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Sodium Valproate is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Sodium Valproate include Sanofi, Fresenius Kabi, AbbVie, Zentiva, Wockhardt, Hikma Farmaceutica, Desitin Pharmaceuticals and Athenex, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Sodium Valproate market in terms of revenue (US$ million) and, where applicable, sales volume (W Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Sodium Valproate Market by Company
Sanofi
Fresenius Kabi
AbbVie
Zentiva
Wockhardt
Hikma Farmaceutica
Desitin Pharmaceuticals
Athenex
Sodium Valproate Segment by Type
Tablet
Liquid
Injection
Sodium Valproate Segment by Application
Epilepsy
Migraines
Others
Sodium Valproate Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sodium Valproate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sodium Valproate and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sodium Valproate.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Sodium Valproate manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Sodium Valproate by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Sodium Valproate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tablet
- Liquid
- Injection
Applications
- Epilepsy
- Migraines
- Others
Companies covered
- Sanofi
- Fresenius Kabi
- AbbVie
- Zentiva
- Wockhardt
- Hikma Farmaceutica
- Desitin Pharmaceuticals
- Athenex
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Sodium Valproate Market Size (2021-2032)
- 2.2.2 Global Sodium Valproate Sales (2021-2032)
- 2.2.3 Global Sodium Valproate Market Average Price (2021-2032)
- 2.3 Sodium Valproate by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Tablet
- 2.3.3 Liquid
- 2.3.4 Injection
- 2.4 Sodium Valproate by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Epilepsy
- 2.4.3 Migraines
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Sodium Valproate Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Sodium Valproate Sales (W Tons) of Manufacturers (2021-2026)
- 3.3 Global Sodium Valproate Revenue of Manufacturers (2021-2026)
- 3.4 Global Sodium Valproate Average Price by Manufacturers (2021-2026)
- 3.5 Global Sodium Valproate Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Sodium Valproate, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Sodium Valproate, Product Type & Application
- 3.8 Global Manufacturers of Sodium Valproate, Established Date
- 3.9 Global Sodium Valproate Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Sanofi
- 4.1.1 Sanofi Company Information
- 4.1.2 Sanofi Business Overview
- 4.1.3 Sanofi Sodium Valproate Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Sanofi Sodium Valproate Product Portfolio
- 4.1.5 Sanofi Recent Developments
- 4.2 Fresenius Kabi
- 4.2.1 Fresenius Kabi Company Information
- 4.2.2 Fresenius Kabi Business Overview
- 4.2.3 Fresenius Kabi Sodium Valproate Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Fresenius Kabi Sodium Valproate Product Portfolio
- 4.2.5 Fresenius Kabi Recent Developments
- 4.3 AbbVie
- 4.3.1 AbbVie Company Information
- 4.3.2 AbbVie Business Overview
- 4.3.3 AbbVie Sodium Valproate Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 AbbVie Sodium Valproate Product Portfolio
- 4.3.5 AbbVie Recent Developments
- 4.4 Zentiva
- 4.4.1 Zentiva Company Information
- 4.4.2 Zentiva Business Overview
- 4.4.3 Zentiva Sodium Valproate Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Zentiva Sodium Valproate Product Portfolio
- 4.4.5 Zentiva Recent Developments
- 4.5 Wockhardt
- 4.5.1 Wockhardt Company Information
- 4.5.2 Wockhardt Business Overview
- 4.5.3 Wockhardt Sodium Valproate Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Wockhardt Sodium Valproate Product Portfolio
- 4.5.5 Wockhardt Recent Developments
- 4.6 Hikma Farmaceutica
- 4.6.1 Hikma Farmaceutica Company Information
- 4.6.2 Hikma Farmaceutica Business Overview
- 4.6.3 Hikma Farmaceutica Sodium Valproate Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Hikma Farmaceutica Sodium Valproate Product Portfolio
- 4.6.5 Hikma Farmaceutica Recent Developments
- 4.7 Desitin Pharmaceuticals
- 4.7.1 Desitin Pharmaceuticals Company Information
- 4.7.2 Desitin Pharmaceuticals Business Overview
- 4.7.3 Desitin Pharmaceuticals Sodium Valproate Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Desitin Pharmaceuticals Sodium Valproate Product Portfolio
- 4.7.5 Desitin Pharmaceuticals Recent Developments
- 4.8 Athenex
- 4.8.1 Athenex Company Information
- 4.8.2 Athenex Business Overview
- 4.8.3 Athenex Sodium Valproate Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Athenex Sodium Valproate Product Portfolio
- 4.8.5 Athenex Recent Developments
5 Global Sodium Valproate Market Scenario by Region
- 5.1 Global Sodium Valproate Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Sodium Valproate Sales by Region: 2021-2032
- 5.2.1 Global Sodium Valproate Sales by Region: 2021-2026
- 5.2.2 Global Sodium Valproate Sales by Region: 2027-2032
- 5.3 Global Sodium Valproate Revenue by Region: 2021-2032
- 5.3.1 Global Sodium Valproate Revenue by Region: 2021-2026
- 5.3.2 Global Sodium Valproate Revenue by Region: 2027-2032
- 5.4 North America Sodium Valproate Market Facts & Figures by Country
- 5.4.1 North America Sodium Valproate Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Sodium Valproate Sales by Country (2021-2032)
- 5.4.3 North America Sodium Valproate Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Sodium Valproate Market Facts & Figures by Country
- 5.5.1 Europe Sodium Valproate Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Sodium Valproate Sales by Country (2021-2032)
- 5.5.3 Europe Sodium Valproate Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Sodium Valproate Market Facts & Figures by Country
- 5.6.1 Asia Pacific Sodium Valproate Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Sodium Valproate Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Sodium Valproate Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Sodium Valproate Market Facts & Figures by Country
- 5.7.1 South America Sodium Valproate Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Sodium Valproate Sales by Country (2021-2032)
- 5.7.3 South America Sodium Valproate Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Sodium Valproate Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Sodium Valproate Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Sodium Valproate Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Sodium Valproate Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Sodium Valproate Sales by Type (2021-2032)
- 6.1.1 Global Sodium Valproate Sales by Type (2021-2032) & (W Tons)
- 6.1.2 Global Sodium Valproate Sales Market Share by Type (2021-2032)
- 6.2 Global Sodium Valproate Revenue by Type (2021-2032)
- 6.2.1 Global Sodium Valproate Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Sodium Valproate Revenue Market Share by Type (2021-2032)
- 6.3 Global Sodium Valproate Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Sodium Valproate Sales by Application (2021-2032)
- 7.1.1 Global Sodium Valproate Sales by Application (2021-2032) & (W Tons)
- 7.1.2 Global Sodium Valproate Sales Market Share by Application (2021-2032)
- 7.2 Global Sodium Valproate Revenue by Application (2021-2032)
- 7.2.1 Global Sodium Valproate Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Sodium Valproate Revenue Market Share by Application (2021-2032)
- 7.3 Global Sodium Valproate Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Sodium Valproate Value Chain Analysis
- 8.1.1 Sodium Valproate Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Sodium Valproate Production Mode & Process
- 8.2 Sodium Valproate Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Sodium Valproate Distributors
- 8.2.3 Sodium Valproate Customers
9 Global Sodium Valproate Analyzing Market Dynamics
- 9.1 Sodium Valproate Industry Trends
- 9.2 Sodium Valproate Industry Drivers
- 9.3 Sodium Valproate Industry Opportunities and Challenges
- 9.4 Sodium Valproate Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst